{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#webpage",
"url": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech",
"name": "Driving a Faster Respiratory Clinical Trial for a Biotech",
"description": "Explore this Fortrea Case Study highlighting how data-driven strategies, patient recruitment expertise, and operational excellence accelerated respiratory clinical trial delivery for a biotech sponsor developing therapies for respiratory disease. Facing challenges related to patient enrollment, study timelines, site performance, and protocol compliance, the sponsor required a scalable approach to improve recruitment efficiency while maintaining high-quality study execution. Fortrea implemented a comprehensive strategy that combined clinical trial feasibility insights, global enrollment planning, real-time analytics, centralized oversight, and proactive site engagement to identify opportunities for performance optimization and accelerate recruitment activities. By leveraging data-driven decision-making and continuous operational monitoring, Fortrea helped improve site productivity, enhance enrollment performance, support protocol compliance, and drive study efficiency across the clinical program. The case study demonstrates how strategic collaboration, respiratory therapeutic expertise, patient-focused recruitment approaches, and advanced clinical trial analytics contributed to faster trial execution and successful study delivery. Through a combination of operational leadership, enrollment optimization, and performance-driven clinical development strategies, Fortrea helped the sponsor advance respiratory drug development objectives while reducing timelines and improving overall clinical trial performance."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Driving a Faster Respiratory Clinical Trial for a Biotech",
"item": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#webpage"
},
"headline": "Accelerating Respiratory Clinical Trials Through Recruitment and Data-Driven Execution | Fortrea Case Study",
"description": "Explore this Fortrea Case Study highlighting how data-driven strategies, patient recruitment expertise, and operational excellence accelerated respiratory clinical trial delivery for a biotech sponsor developing therapies for respiratory disease. Facing challenges related to patient enrollment, study timelines, site performance, and protocol compliance, the sponsor required a scalable approach to improve recruitment efficiency while maintaining high-quality study execution. Fortrea implemented a comprehensive strategy that combined clinical trial feasibility insights, global enrollment planning, real-time analytics, centralized oversight, and proactive site engagement to identify opportunities for performance optimization and accelerate recruitment activities. By leveraging data-driven decision-making and continuous operational monitoring, Fortrea helped improve site productivity, enhance enrollment performance, support protocol compliance, and drive study efficiency across the clinical program. The case study demonstrates how strategic collaboration, respiratory therapeutic expertise, patient-focused recruitment approaches, and advanced clinical trial analytics contributed to faster trial execution and successful study delivery. Through a combination of operational leadership, enrollment optimization, and performance-driven clinical development strategies, Fortrea helped the sponsor advance respiratory drug development objectives while reducing timelines and improving overall clinical trial performance.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-28",
"dateModified": "2026-04-28",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/driving-faster-respiratory-clinical-trial-biotech.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#webpage",
"url": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech",
"name": "Driving a Faster Respiratory Clinical Trial for a Biotech",
"description": "Explore this Fortrea Case Study highlighting how data-driven strategies, patient recruitment expertise, and operational excellence accelerated respiratory clinical trial delivery for a biotech sponsor developing therapies for respiratory disease. Facing challenges related to patient enrollment, study timelines, site performance, and protocol compliance, the sponsor required a scalable approach to improve recruitment efficiency while maintaining high-quality study execution. Fortrea implemented a comprehensive strategy that combined clinical trial feasibility insights, global enrollment planning, real-time analytics, centralized oversight, and proactive site engagement to identify opportunities for performance optimization and accelerate recruitment activities. By leveraging data-driven decision-making and continuous operational monitoring, Fortrea helped improve site productivity, enhance enrollment performance, support protocol compliance, and drive study efficiency across the clinical program. The case study demonstrates how strategic collaboration, respiratory therapeutic expertise, patient-focused recruitment approaches, and advanced clinical trial analytics contributed to faster trial execution and successful study delivery. Through a combination of operational leadership, enrollment optimization, and performance-driven clinical development strategies, Fortrea helped the sponsor advance respiratory drug development objectives while reducing timelines and improving overall clinical trial performance."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Driving a Faster Respiratory Clinical Trial for a Biotech",
"item": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/driving-faster-respiratory-clinical-trial-biotech#webpage"
},
"headline": "Accelerating Respiratory Clinical Trials Through Recruitment and Data-Driven Execution | Fortrea Case Study",
"description": "Explore this Fortrea Case Study highlighting how data-driven strategies, patient recruitment expertise, and operational excellence accelerated respiratory clinical trial delivery for a biotech sponsor developing therapies for respiratory disease. Facing challenges related to patient enrollment, study timelines, site performance, and protocol compliance, the sponsor required a scalable approach to improve recruitment efficiency while maintaining high-quality study execution. Fortrea implemented a comprehensive strategy that combined clinical trial feasibility insights, global enrollment planning, real-time analytics, centralized oversight, and proactive site engagement to identify opportunities for performance optimization and accelerate recruitment activities. By leveraging data-driven decision-making and continuous operational monitoring, Fortrea helped improve site productivity, enhance enrollment performance, support protocol compliance, and drive study efficiency across the clinical program. The case study demonstrates how strategic collaboration, respiratory therapeutic expertise, patient-focused recruitment approaches, and advanced clinical trial analytics contributed to faster trial execution and successful study delivery. Through a combination of operational leadership, enrollment optimization, and performance-driven clinical development strategies, Fortrea helped the sponsor advance respiratory drug development objectives while reducing timelines and improving overall clinical trial performance.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-04-28",
"dateModified": "2026-04-28",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/driving-faster-respiratory-clinical-trial-biotech.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Case Study